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and tumor necrosis factor alpha; this stimulation is enhanced
by gamma interferon (13). Superantigens bind to different sites
on the MHC class II molecule. For example, SEA can compete
with SEB (10) and toxic shock syndrome toxin 1 (TSST-1),
another staphylococcal superantigen, for binding to the MHC
class II molecule, but SEB and TSST-1 cannot compete with
SEA for binding (8). The structure of TSST-1 complexed with
HLA-DR1 shows that TSST-1 binds to a region of the MHC
class II a chain similar to that bound by SEB, but with significant differences (25). SEA and SEE require zinc to bind the
MHC class II molecule, while SEB binding was not affected by
EDTA (12). Mutations at positions 81, 137, and 152 of the b
chain of HLA-DR1 affect binding of SEA but not SEB, suggesting that SEA binds the a and b chains of the MHC class II
molecule (3, 19).
The relationship between the emetic and the superantigen
activities of the SEs is unclear. Some investigators suggest that
the high levels of interleukin-2 production provoked by superantigen exposure lead to emesis, similar to the emetic effect of
chemotherapeutic interleukin-2 treatment (35). A growing body
of data indicates, however, that the two activities are separable.
One group showed that carboxymethylated SEB (CM-SEB) is
unable to induce emesis and can block the emetic activity
of SEB (32), while a separate study showed that CM-SEB is
active in a primate T-cell proliferation assay (2). Mutational
analysis of SEA and SEB has also shown that the two activities
can be separated (14, 15). Residues 25, 47, and 48 of SEA are
required for the superantigen activity of SEA, with residue 25
interacting with the TCR and residues 47 and 48 playing a role
in MHC class II molecule binding (14). However, some mutations at these positions which result in loss of superantigen
activity do not cause loss of emetic activity.
Earlier chemical modification of the histidine residues of
SEA showed that CM-SEA is unable to provoke an emetic
response in monkeys (40); CM-SEA was not tested for concomitant superantigen activity. In the present study, CM-SEA

Staphylococcal enterotoxins (SEs) induce emesis and are the
causative agents of staphylococcal food poisoning (5). Five
serological groups of SEs, SEA through SEE, have been characterized, with SEC having multiple subtypes. The genes for
each of these toxins have been cloned. On the basis of the
homology between their predicted amino acid sequences, SEs
can be divided into two groups, one with SEA, SED, and SEE
and the other with SEB and the SECs (reviewed in reference
6). A recently identified staphylococcal exotoxin which induces
shock in rabbits, called SEH, shares considerable amino acid
sequence identity with SEA, SED, and SEE (33); a separate
study showed that a protein also designated as SEH, with the
same 35 amino-terminal residues, is emetic (41).
In addition to causing emesis, the SEs are members of a
group of potent immunological activators called superantigens
(29). The hallmark activity of a superantigen is the ability to
stimulate T cells in a manner dependent on the Vb sequence
of the T-cell receptor (TCR). Like conventional exogenous
antigens, superantigens must be presented to T cells by a class
II major histocompatibility complex (MHC) molecule. Unlike
conventional antigens, superantigens do not require processing
and are displayed outside of the peptide binding groove (9).
The three-dimensional structure of SEB has been determined,
which, in conjunction with mutagenesis data, allows prediction
of sites in SEB which make contact with the TCR (24, 42).
Further, the three-dimensional structure of SEB complexed
with the human MHC class II molecule HLA-DR1 allows
identification of SEB residues which make direct contact with
the a chain of the MHC class II molecule (22).
SE binding to MHC class II is sufficient to stimulate macrophages to produce the inflammatory cytokines interleukin-1
* Corresponding author. Mailing address: 304 Fred Hall, 1550 Linden Dr., Madison, WI 53706. Phone: (608) 265-8431. Fax: (608) 2629865. Electronic mail address: mahoffmn@macc.wisc.edu.
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The goal of this study was to examine the role of histidine residues in the biological activities of staphylococcal enterotoxin A (SEA). Carboxymethylated SEA was unable to stimulate murine T-cell proliferation but
was resistant to monkey stomach lavage fluid degradation, suggesting that native conformation was intact.
Site-directed mutagenesis of the histidine residues of SEA was subsequently performed. SEA-H44A (SEA with
histidine 44 replaced with alanine), SEA-H44D, SEA-H50A, SEA-H50D, SEA-H114A, SEA-H114D, SEAH187A, and SEA-H187D retained superantigen and emetic activities, whereas SEA-H225A and SEA-H225D
were defective in the ability to stimulate T-cell proliferation. These mutants were unable to compete with SEA
for binding to Raji cells, suggesting that the defect in SEA-H225A and SEA-H225D is due to impaired major
histocompatibility complex class II binding. SEA-H225D provoked an emetic response in monkeys only if fed
at high doses, while SEA-H225A did not provoke an emetic response at low or high doses. In comparison,
SEA-H61A and SEA-H61D were defective in emetic activity but not in the ability to stimulate murine T-cell
proliferation. Overall, these studies show that the carboxy-terminal histidine at residue position 225 of SEA is
important for both the superantigen and emetic activities of this enterotoxin. Histidine 61 appears to be
important for emetic activity but not for superantigen activity, consistent with the hypothesis that the two
activities are separable in staphylococcal enterotoxins.
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TABLE 1. Mutant sea alleles
Mutant
allele

Template

sea

sea-1401

sea-1364

sea-1402
sea-1403
sea-1404
sea-1405
sea-1406
sea-1407

sea-1364
sea-1364
sea-1364
sea-1364
sea-1364
sea-1325

sea-1408
sea-1409
sea-1410
sea-1411
sea-1412

sea-1325
sea-1325
sea-1325
sea-1325
sea-1325

A483G
T489C
G537A
G615A, A618C
T619C
T637A, C638G
C202G, A203T
C204T
C202G
C220G, A221C
C220G
C253G, A254C
C253G
C412G, A413C
T423C
C412G, A426T
C631G, A632C
C631G
C734G, A735C
C734G

Effectb

KpnI
StyI
BglII
StuI
SpeI
H44A, PstI 2
H44D, PstI 2
H50A, PstI 2
H50D, PstI 2
H61A, SpeI 2
H61D, SpeI 2
H114A, ClaI 2
H114D, ClaI 2
H187A, SpeI 2
H187D, SpeI 2
H225A, NsiI 2
H225D, NsiI 2

a
The nucleotide indicated at the left of the indicated position was changed to
the nucleotide indicated at the right.
b
Amino acid substitution or restriction site created or lost (2) by substitution.

and SEA with the individual histidine residues at positions 44,
50, 61, 114, 187, and 225 substituted by site-directed mutagenesis were tested for the ability to stimulate murine T-cell proliferation and for susceptibility to monkey stomach fluid degradation. Further, mutants which were defective in the ability
to stimulate T-cell proliferation were tested by flow cytometry
for the ability to compete with SEA for MHC class II binding
to Raji cells, which constitutively express HLA-DR.
MATERIALS AND METHODS
Bacterial strains and media. Escherichia coli and Staphylococcus aureus were
grown under established conditions (20). S. aureus was grown in 3% (wt/vol) N-Z
amine type A (Kraft, Inc., Norwich, N.Y.)–1% yeast extract (Difco Laboratories,
Detroit, Mich.) at 378C with aeration (200 rpm) for 16 to 18 h and then harvested
by centrifugation. Nalgene filters (0.45-mm pore size; Nalge Co., Rochester,
N.Y.) were used to sterilize culture supernatants before testing.
Chemicals and enzymes. Chemical and enzymatic reagents were obtained
from the following sources: restriction enzymes and T4 ligase were from New
England Biolabs, Inc. (Beverly, Mass.); bromoacetic acid and fluorescein isothiocyanate-avidin were from Sigma Chemical Co. (St. Louis, Mo.); the Sequenase kit was from United States Biochemical (Cleveland, Ohio); and the Unique
Site Elimination kit and CNBr-activated Sepharose 4B were from Pharmacia
Biotec (Milwaukee, Wis.).
Chemical modification. Samples containing 0.3 mg of SEA were incubated
with bromoacetic acid (0.5 M, pH 6.8) or potassium phosphate buffer (0.5 M, pH
6.8) as a negative control for 14 days in the dark at room temperature. The
samples subsequently were dialyzed extensively against phosphate-buffered saline (PBS; 0.02 M sodium phosphate, 0.15 M NaCl [pH 7.4]) to remove the
bromoacetic acid and were concentrated with Centricon-10 units (Amicon Division, W. R. Grace & Co., Beverly, Mass.). Amino acid analysis of the carboxymethylated samples was performed at the Medical College of Wisconsin’s
Protein/Nucleic Acid Shared Facility of the Cancer Center (Milwaukee).
Site-directed mutagenesis. The sea allele used as a template for mutagenesis
was sea-1364 (15) or sea-1325 with unique restriction sites in the coding regions
for the N terminus or the C terminus of SEA, respectively. Sequential rounds of
mutagenesis (27) were used to construct sea-1325 (Table 1).
The Unique Site Elimination kit (Pharmacia) was used to construct most of
the altered sea alleles, with the exception of mutations resulting in sea-1410 and
sea-1412; PCR was performed to make sea-1410, and modified Kunkel mutagenesis (27) was used to construct sea-1412. All mutations were confirmed by DNA
sequence analysis (36). Table 1 describes the specific nucleotide substitutions
made for each mutant sea as well as the resulting amino acid substitutions and
changes in unique restriction sites which resulted from these substitutions.
Following confirmation of the mutation, the plasmid with the mutant sea was
digested with HindIII and ligated to HindIII-cut pC194 (20, 21). The resulting

RESULTS
Carboxymethylation of SEA. An earlier study using CMSEA did not test the modified toxin for its ability to stimulate
T-cell proliferation and did not determine whether the loss of
emetic activity was due to degradation by stomach fluid (40).
To address these questions in the present study, SEA was
carboxymethylated to further characterize CM-SEA. The modification was successful in that an average of 5.5 of the 6
histidine residues were modified as determined by amino acid
analysis. CM-SEA was able to bind polyclonal antisera against
SEA (Fig. 1A) and MAbs C1 and E8 (data not shown), consistent with the earlier report that CM-SEA is not significantly
altered in conformation (40). CM-SEA was tested for its ability
to stimulate murine T-cell proliferation and did not produce a
statistically significant response compared with SEA (Fig. 1B).
CM-SEB, in contrast, was able to stimulate primate T cells to
proliferate (2). CM-SEA was tested for susceptibility to degradation by monkey stomach fluid in an in vitro assay. Compared with SEA-V85G, a mutant SEA susceptible to degradation in monkey stomach fluid (15), CM-SEA was found to be
resistant to degradation under these conditions, suggesting
that the loss of emetic activity was probably not due to degradation (Fig. 1A). These findings suggested that one or more
histidine residues play a role in the superantigen and emetic
activities of SEA.
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sea-1325

Site-directed
mutation(s)a

plasmids were then electroporated into S. aureus RN4220 (20, 26). Generalized
transduction with phage 80} (30) was used to introduce the plasmids into the
protein A-negative S. aureus strain ISP2073 (31).
Serological assays. Western blots (immunoblots) and gel double-diffusion
assays were performed by using established protocols (20, 34). The polyclonal
antisera used were the gift of Merlin Bergdoll (University of Wisconsin—Madison); the monoclonal antibodies (MAbs) C1 and E8 have been characterized
previously (16).
Murine T-cell proliferation assay. Splenocytes from 6- to 8-week-old BALB/c
female mice (Harlan, Sprague, Dawley, Madison, Wis.) were used in T-cell
proliferation assays (20). Dilutions of culture supernatants containing SEA,
mutant SEAs, or purified samples (including chemically modified SEA) were
incubated at 5.0, 0.5, or 0.05 mg per well. The extent of proliferation was
determined by measuring the incorporation of [3H]thymidine. The degree of
statistical significance (P , 0.01) was determined by Student’s t test, using
Minitab (Minitab, Inc.).
Purification of SEs. SEA, SEA-H225A, and SEA-H225D were purified from
protein A-negative strains by immunoaffinity chromatography with MAb C1 as
described previously (15). Purity of samples was determined by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. The concentration of the purified
samples was determined by UV adsorption at 277 nm, using an extinction
coefficient of 12.76 (39).
MHC class II receptor binding assay. Samples containing various amounts of
purified SEA or mutant SEA were coincubated with 5 mg of biotinylated SEA
(Toxin Technologies, Sarasota, Fla.) per ml and Raji cells (5 3 106 cells per ml),
washed with FC buffer (PBS [pH 6.8], 1% bovine serum albumin, 0.1% NaN3),
and incubated with fluorescein isothiocyanate-avidin (10 mg/ml). Binding was
determined by flow cytometry using a FACScan (Becton Dickinson Immunocytometry Systems, San Jose, Calif.) flow cytometer (14).
Stomach fluid degradation assay. Samples with culture supernatants containing SEA, CM-SEA, and control SEA in PBS or supernatants containing mutant
SEAs were incubated with monkey stomach lavage fluid or PBS for 2 h at 378C.
The stomach fluid was obtained by sterile lavage with 15 ml of 0.9% (wt/vol)
NaCl solution (Abbott Laboratories, Chicago, Ill.) from rhesus monkeys (Macaca mulatta). The samples were then tested by Western blot (immunoblot)
analysis. SEA-V85G, previously shown to degrade in stomach fluid, was used as
a positive degradation control (15).
Emetic assays. SEA is able to stimulate a strong emetic response in monkeys
at a dose of 100 mg per animal. Sterilized culture supernatants from RN4220
derivatives containing 100 mg of mutant SEA were administered by nasogastric
intubation to rhesus monkeys weighing 2 to 3 kg. The amount of SEA (or mutant
SEA) in RN4220 culture supernatants was determined by serial dilution and
comparison with quantitated purified SEA (15). The monkeys were observed for
5 h. Samples which did not induce an emetic response at the dose were tested at
500 mg per animal. The samples containing higher amounts were prepared by
concentrating culture supernatants with Amicon Centriprep units. RN4220 supernatants served as a negative control for these experiments. Emetic assays
were done in collaboration with the Wisconsin Regional Primate Research
Center, Madison.
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Serological characterization of mutant SEAs. To identify
the specific histidine residues involved in the superantigen and
emetic activities of SEA, mutant SEAs were constructed by
site-directed mutagenesis. Aspartic acid substitutions were
made in order to mimic the results obtained by acidic modification. Alanine substitutions were made to address the possibility that the aspartic acid substitutions do not affect metal
binding and because aspartic acid is found at some analogous
positions in other SEs (4). The production of immunoreactive
material by these mutant alleles was confirmed by gel doublediffusion assays and Western blot analysis of S. aureus RN4220
supernatants, using polyclonal antisera raised against SEA
(data not shown). The plasmids were then transduced into the
protein A-negative S. aureus strain ISP2073, and these strains
were used for further analysis of the mutants.
All of the mutant SEAs formed a band of identity with
polyclonal antisera raised against SEA in both gel doublediffusion assays and Western blots. All mutants were also able
to form a band of identity with MAb C1, which recognizes an
epitope in residues 108 to 230 of SEA, and with MAb E8 (data
not shown), which recognizes a conformational epitope (16).
None of the mutants were degraded by incubation with monkey stomach lavage fluid (Fig. 2), which was a further indication that the substitutions did not result in significant confor-
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mational change in the proteins that would expose buried
protease cleavage sites.
T-cell stimulation by mutant SEAs. Culture supernatants
from ISP2073 derivatives producing SEA or mutant SEAs
were tested for the ability to stimulate murine splenocyte proliferation. Dilutions of each supernatant were tested in triplicate wells. Substitution of the histidine at position 44, 61, 114,
or 187 with either alanine or aspartic acid did not affect the
ability of SEA to stimulate murine T-cell proliferation (Fig.
3A). SEA-H50D and SEA-H114A stimulated a lower level of
proliferation than did SEA, but the proliferative response was
statistically significant (P , 0.01) compared with the negative
control. SEA-H225A and SEA-H225D were inactive in the
murine T-cell proliferation assay.
SEA-H225A and SEA-H225D were purified by immunoaffinity chromatography to determine if they could stimulate
T-cell proliferation at concentrations higher than those found
in culture supernatants. When tested at 5, 0.5, and 0.05 mg per
well, these mutant SEAs were unable to stimulate T-cell proliferation (Fig. 3B), indicating that the histidine at position 225
plays an important role in the superantigen activity of SEA.
Binding of SEA-H225A and SEA-H225D to MHC class II
molecules. Two types of mutations would potentially affect the
superantigen activity of SEA: a defect in MHC class II binding
or a defect in the ability to bind the TCR. Because MHC class
II binding is prerequisite for optimal interaction with the TCR
and because MHC class II binding alone is sufficient to stimulate inflammatory cytokine production, we tested these mutants for the ability to bind Raji cells, which constitutively
express HLA-DR1. Neither SEA-H225A nor SEA-H225D was
able to compete effectively with biotinylated SEA for binding
to Raji cells (Fig. 4). This finding provides evidence that histidine 225 plays a role in the MHC class II binding of SEA.
Emetic activity of mutant SEAs. All of the mutants resistant
to degradation by monkey stomach fluid in an in vitro assay
(Fig. 2), with the exception of SEA-H114A and SEA-H114D,
were tested for emetic activity. SEA-H114A and SEA-H114D
were not tested because SEA with a deletion of this histidine
residue and SEA-H114R were emetic when fed at 100 mg
per animal (19a). SEA-H44A, SEA-H44D, SEA-H50A, SEAH50D, SEA-H187A, and SEA-H187D were emetic at 100 mg
per animal (Table 2). A mutant SEA which induces a response
in at least one animal is considered emetic, but comparisons

FIG. 2. Incubation of mutant SEAs with monkey stomach lavage fluid. Culture supernatants containing SEA or mutant SEAs, including SEA-V85G as a
control, were incubated with PBS (2) or stomach fluid (1) and then subjected
to Western blotting. The blots were detected with polyclonal antisera raised
against SEA.
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FIG. 1. Characterization of CM-SEA. (A) Western blot comparing SEAV85G (culture supernatant in ISP2073 background), SEA (5 mg/ml, initial concentration), and CM-SEA (5 mg/ml, initial concentration) for susceptibility to
stomach fluid degradation and ability to bind polyclonal antiserum against SEA.
Lanes: 2, samples incubated with PBS; 1, samples incubated with monkey
stomach lavage fluid. (B) Induction of T-cell proliferation by SEA and CM-SEA.
Samples were incubated with murine splenocytes for 72 h and then pulsed with
[3H]thymidine for 18 h. Results are means of a representative experiment in
which each sample was tested in triplicate. Data shown are representative of at
least three separate proliferation assays.
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between emetic samples cannot be made because of limited
availability of monkeys. SEA-H61A and SEA-H61D did not
provoke an emetic response when fed at 100 mg per animal.
When tested at 500 mg per animal, neither SEA-H61A nor
SEA-H61D provoked an emetic response in any of the six
animals tested (Table 2). SEA-H225D did not provoke an
emetic response at 100 mg per animal but did cause emesis in
two of six monkeys at 500 mg per animal (Table 2). SEAH225A was not tested at 100 mg per animal because SEAH225D was emetic only at the higher dose and was not emetic
at 500 mg per monkey (Table 2).

DISCUSSION
This study identifies two histidine residues of SEA which are
important for the biological activities of this enterotoxin, confirming and extending an earlier finding which suggested that
histidine residues play a role in the emetic activity of SEA (40).
Other data also indicate that the histidine residues of SEA may
be important for biological activity. Sequence analysis of the
SEs shows that the histidine at position 114 is conserved
among all SEs characterized. The zinc requirement for MHC
class II binding implicates amino acids which are able to bind

TABLE 2. Emetic activities of SEAs
No. of monkeys exhibiting emesis

FIG. 4. MHC class II binding assay with SEA-H225A and SEA-H225D.
Various concentrations of SEA (h), SEA-H225A (F), and SEA-H225D (})
were tested for the ability to compete with biotinylated SEA for binding to Raji
cells. Results are mean fluorescence of the cells following incubation with fluorescein isothiocyanate-avidin and detection by flow cytometry.

Samplea

Stomach
fluidb

RN-4220
SEA
SEA-V85G
SEA-H44A
SEA-H44D
SEA-H50A
SEA-50D
SEA-H61A
SEA-H61D
SEA-H187A
SEA-H187D
SEA-H225A
SEA-H225D

NT
R
S
R
R
R
R
R
R
R
R
R
R

100 mg/animal
(3 animals/group)

500 mg/animal
(6 animals/group)

0
3
NT
3
3
1
1
0
0
1
1
NT
0

NT
NT
NT
NT
NT
NT
NT
0
0
NT
NT
0
2

a
Samples were in RN4220 culture supernatants which had been filter sterilized.
b
NT, not tested; R, sample is resistant to degradation by monkey stomach
lavage fluid; S, sample is sensitive to degradation by monkey stomach lavage
fluid.

Downloaded from http://iai.asm.org/ on January 19, 2018 by guest

FIG. 3. Induction of T-cell proliferation by mutant SEAs in culture supernatants from ISP2073 (Sea2; negative control) or derivatives expressing either SEA or a
mutant SEA (A) or purified SEA-H225A and SEA-H225D (B). Samples were incubated with murine splenocytes for 72 h and then pulsed with [3H]thymidine for
18 h. Results are means of a representative experiment in which each sample was tested in triplicate. Data shown are representative of at least three separate
proliferation assays.
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substitution affects MHC class II binding (1). Our finding that
SEA-H187A and SEA-H187D have superantigen activity and
the report that SED has an aspartic acid at this position (4)
indicate that residues other than histidine can be functional at
this position. SEA-H225A and SEA-H225D were unable to
stimulate T-cell proliferation, even at high amounts. These
mutants were also unable to compete with biotinylated SEA
for binding to cell surface-expressed MHC class II molecules.
The histidine at position 225 is also important for emetic activity because SEA-H225D was emetic only when fed at 500 mg
per animal and SEA-H225A was not emetic at 500 mg per
animal.
SEA-H61A and SEA-H61D are the first mutant SEAs to be
described with activity in the murine splenocyte proliferation
assay that are altered in their emetic activities. The finding that
SEA-H225D is emetic at the higher dose but does not stimulate T-cell proliferation is also consistent with earlier findings
that the two activities do not perfectly correlate. However, it is
worth noting that SEAs with mutations at sites in both the
amino- and carboxy-terminal regions which affect MHC class
II binding (residues 47, 48, and 225) have altered emetic activity. The nature of the substitution influences the degree of
the effect on emetic activity; for example, SEA-F47S (14) and
SEA-H225D are emetic at 500 mg per animal, while SEAF47G (15) and SEA-H225A are not.
The identification of a specific amino acid in the C terminus
of SEA which is important for MHC class II binding is consistent with the finding that a recombinant peptide consisting of
residues 107 to 233 (18) is able bind the MHC class II molecule. Inspection of the SEA three-dimensional structure suggests that this residue is on the opposite face of the molecule
relative to the predicted N-terminal MHC class II binding site.
This finding indicates that SEA has two distinct MHC class II
binding sites, consistent with the cross-linking model proposed
by Jardtzky et al. (22). The two sites seem to be cooperative
because substitutions at either site affect MHC class II molecule binding (this work and references 1 and 14).
The three-dimensional structure of SEA indicates that the
amino acids which bind a metal atom are serine 1, histidines
187 and 225, and the aspartic acid at position 227 (37). The
inability of mutants at position 225 to compete with biotinylated SEA for binding to the MHC class II molecule can be
attributed to inability to bind zinc. However, the T-cell-stimulatory activity of substitutions at histidine 187 suggest that this
residue is not vital for metal binding, consistent with the report
of Abrahmsen et al. that SEA with an alanine at this position
is able to bind the MHC class II molecule, though more weakly
than SEA (1). The different emetic activities of SEA-H225A
and SEA-H225D suggest that zinc binding could play a role in
the emetic activity of SEA. While we were unable to show that
SEA-H225D is able to compete for binding to the MHC class
II receptor, it is possible that in the gastrointestinal tract, this
mutant is able to bind zinc whereas SEA-H225A is not.
In summary, this study identifies histidine residues in SEA
which play a role in the emetic and superantigen activities of
this molecule. Histidine 61 was shown to be important for
emetic activity but not for the ability to stimulate murine T-cell
proliferation. A carboxy-terminal residue in the metal binding
site of SEA important for MHC class II binding and emetic
activity was identified. This is the first examination of the role
of the metal binding site in the emetic activity of SEA and the
first identification of a specific carboxy-terminal residue which
plays a role in the emetic activity of SEA. The results reported
in this paper are consistent with earlier findings that activity in
a murine T-cell proliferation assay is not predictive of emetic
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zinc; cysteine and histidine residues are commonly found in
zinc coordination sites, with aspartic acid and glutamic acid
also common. The two cysteines of SEA form a stable disulfide
bond and are unlikely to be directly involved in zinc coordination. The histidines at positions 187 and 225 are found in both
SEA and SEE, which require zinc for the ability to bind the
MHC class II molecule.
CM-SEA is unable to stimulate murine T-cell proliferation,
demonstrating that one or more histidine residues of SEA are
required for superantigen activity. This contrast with CM-SEB
is not surprising since only the histidine at position 114 is
conserved between the two. CM-SEA was not susceptible to
degradation by stomach fluid (Fig. 1), suggesting that the lack
of emetic activity reported in the earlier study was probably not
due to degradation.
To identify the specific histidine residues which are required
for the emetic and superantigen activities of SEA, site-directed
mutagenesis was performed to create 12 SEAs in which single
histidine residues were replaced with aspartic acid or alanine.
None of the substitutions resulted in significant conformational changes that affected binding of polyclonal antisera to
the mutant proteins or resulted in susceptibility to degradation
by gastric fluid. The binding of MAb C1, which recognizes an
epitope in the C terminus of SEA (16), is not affected by any
of the mutations, including those in the C terminus; MAb E8
is also able to bind all of the mutants. All of the mutant
proteins were resistant to degradation by stomach fluid, indicating that the overall conformation of the mutant proteins was
not altered to expose a buried protease recognition site.
The substitutions at amino-terminal positions 44, 50, and 61
did not affect the ability of SEA to stimulate murine T cells.
Histidines 44 and 50 are near residues 47 and 48, which had
previously shown to be important for the MHC class II binding
activity of SEA (14). In SEB, the five residues at positions 43
to 47, which align with residues 46 to 50 of SEA, make contact
with the a chain of the HLA-DR (22). However, mutations at
positions 46 (14) and 50 in SEA did not dramatically affect
superantigen activity. Also, the histidines at positions 44 and 50
are not required for emetic activity.
Histidine 61 is near a site identified in SEB as being important in determining TCR specificity (17, 24). In SEA, a residue
adjacent to histidine 61, aspartic acid 60, may play a role in
interaction with the murine TCR (15, 28). Histidine 61 is
important for the emetic activity of SEA but is not required for
the ability to stimulate murine T-cell proliferation. One possible explanation for the observed change in emetic activity but
not in murine T-cell stimulation is that this residue is important for primate but not murine TCR binding. It is also possible
that the loss of emetic activity is due to in vivo degradation, in
spite of the in vitro resistance of these mutants to stomach
fluid. Another possible explanation is that the two activities are
indeed distinct and that this residue is required for emesis but
not T-cell activation.
Some mutations in the carboxy-terminal region affected both
activities. Histidine 114 is the only histidine that is conserved
among all of the enterotoxins characterized. Deletion of this
histidine, or substitution of the histidine at this position with
arginine, does not affect the emetic or superantigen activity of
SEA (19a). Both SEA-H114A and SEA-H114D are active in
murine T-cell proliferation assays. Thus, this conserved histidine is not required for emetic or superantigen activity.
Substitution of histidine 187 with an aspartic acid or alanine
did not affect T-cell stimulation or emetic activity, although
this histidine plays a role in the flexibility of the zinc binding
site (36). The activity of SEA-H187A in a murine T-cell proliferation assay is in apparent contrast to the report that this
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activity in primates and add to previous evidence indicating
that the two activities are not clearly linked.
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